Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

EBSEBS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in EMERGENT BIOSOLUTIONS INC

GOLDMAN SACHS GROUP INC holds 1M shares of EBS (EMERGENT BIOSOLUTIONS INC), worth $8.7M as of 2026-Q2. The position was increased (+27.6% shares). EBS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$8.7M

Current Shares

1M

Total Value Change

-$587,501

Total Shares Change

+66,349

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+27.6%
$8.7M0.0%$8.38
34
2026-Q1
Increased
811,560
+9.7%
$6.7M0.0%$8.92
30
2025-Q4
Increased
740,100
+19.2%
$9.1M0.0%$12.16
33
2025-Q3
Increased
620,977
+7.2%
$5.5M0.0%$8.94
29
2025-Q2
Decreased
579,392
-46.9%
$3.7M0.0%$6.35
0
2025-Q1
Increased
1.1M
+12.6%
$5.3M0.0%$4.66
30
2024-Q4
New
969,072
-
$9.3M0.0%$9.25
38

Other major holders of EBS: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used